AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.170
-0.190 (-13.97%)
At close: Jan 22, 2026, 4:00 PM EST
1.180
+0.010 (0.85%)
Pre-market: Jan 23, 2026, 6:29 AM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $13.85 million as of January 23, 2026. Its market cap has decreased by -36.97% in one year.
Market Cap
13.85M
Enterprise Value
26.18M
1-Year Change
-36.97%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $13.85M, a decrease of -78.24%. That is a compound annual growth rate of -27.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 16.10M | 23.64% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Applied Therapeutics | 15.25M |
| Cellectar Biosciences | 14.84M |
| Cocrystal Pharma | 14.47M |
| Soligenix | 13.92M |
| BioCardia | 13.80M |
| NuCana | 13.36M |
| Moleculin Biotech | 13.12M |
| Tempest Therapeutics | 12.71M |